Maximum quantity allowed is 999
Please select the quantity
CAS RN: 144689-63-4 | Product Number: O0510
Olmesartan Medoxomil
Purity: >98.0%(T)(HPLC)
Synonyms:
Product Documents:
Size | Unit Price | Shanghai | Tianjin | Japan* |
---|---|---|---|---|
1G |
¥380.00
|
4 | 1 | 2 |
5G |
¥1,050.00
|
3 | Contact Us | 15 |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
Product Number | O0510 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__9H__3__0N__6O__6 = 558.60 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 144689-63-4 |
Reaxys Registry Number | 7506931 |
PubChem Substance ID | 354335790 |
Merck Index (14) | 6839 |
MDL Number | MFCD00944911 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
NMR | confirm to structure |
Properties (reference)
Melting Point | 180 °C(dec.) |
Solubility in water | Insoluble |
Solubility (slightly sol. in) | Methanol, Acetone |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
RTECS# | NI4014200 |
Transport Information:
Customs Control Conditions (Q) |
Application
Olmesartan Medoxomil: A Prodrug of Olmesartan, a Selective AT1 Subtype Angiotensin II Receptor Antagonist
Olmesartan medoxomil (CS-866), a prodrug, is hydrolyzed to the active metabolite olmesartan [O0507] during absorption from the gastrointestinal tract. Olmesartan is a selective AT1 subtype angiotensin II receptor antagonist (“sartan”). Olmesartan medoxomil is used for the treatment of hypertension. (The product is for research purpose only.)
References
- Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist
- Real-time monitoring of metabolic reactions by microdialysis in combination with tandem mass spectrometry: hydrolysis of CS-866 in vitro in human and rat plasma, livers, and small intestines
- Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sites
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.